Skip to main content
. 2023 Jul 25;2023(7):CD015078. doi: 10.1002/14651858.CD015078

Comparison 1. Individuals with a confirmed diagnosis of COVID‐19 and moderate to severe disease.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 All‐cause mortality up to day 28 3 17249 Risk Ratio (M‐H, Random, 95% CI) 0.95 [0.85, 1.05]
1.2 Worsening up to day 28: participants with new need for invasive mechanical ventilation or death 2 15266 Risk Ratio (M‐H, Random, 95% CI) 0.95 [0.90, 1.01]
1.3 Improvement up to day 28: discharged alive 2 15454 Risk Ratio (M‐H, Random, 95% CI) 1.00 [0.96, 1.04]
1.4 Thrombotic events 4 17518 Risk Ratio (M‐H, Random, 95% CI) 0.90 [0.80, 1.02]
1.5 Serious adverse events 1 1815 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.57 [0.48, 5.14]
1.6 Major bleeding events 4 17527 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.68 [1.29, 2.19]
1.7 Need for new dialysis up to day 28 1 14771 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.99 [0.84, 1.18]
1.8 180‐day mortality 1 1312 Risk Ratio (M‐H, Random, 95% CI) 0.97 [0.82, 1.15]
1.9 All‐cause mortality up to longest follow‐up 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected